Congenital Cytomegalovirus Infection.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
05 03 2020
Historique:
entrez: 6 3 2020
pubmed: 7 3 2020
medline: 2 2 2021
Statut: ppublish

Résumé

Congenital cytomegalovirus (cCMV) infection is a leading cause of hearing loss and neurological disabilities in children, with the disease burden and disabilities due to cCMV greater than many other well recognized childhood conditions. A minority of infants with cCMV will have symptoms at birth. Infants with symptomatic cCMV are at higher risk for sequelae than those born without symptoms. The majority of infants with cCMV are asymptomatic at birth, but 10%-15% will develop hearing loss. Although clinical symptoms can help predict which infants will have sensorineural hearing loss, among asymptomatic cCMV there are currently no predictors of adverse outcome. The identification of a biomarker to identify those at highest risk of sequelae is highly desirable to target interventions to those who could potentially benefit. Because there is increasing rationale for establishing both targeted and universal screening programs for cCMV in the United States and worldwide, this is an urgent priority.

Identifiants

pubmed: 32134480
pii: 5781897
doi: 10.1093/infdis/jiz446
pmc: PMC8453618
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S9-S14

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC012661
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

JAMA Pediatr. 2016 Dec 1;170(12):1173-1180
pubmed: 27723885
JAMA. 2010 Apr 14;303(14):1375-82
pubmed: 20388893
J Infect Dis. 2019 Jul 31;220(5):781-791
pubmed: 31050742
J Clin Virol. 2009 Dec;46 Suppl 4:S6-10
pubmed: 19800841
N Engl J Med. 2011 Jun 2;364(22):2111-8
pubmed: 21631323
Infect Dis Clin North Am. 2015 Sep;29(3):401-14
pubmed: 26154664
Pediatr Infect Dis J. 2009 Jul;28(7):588-92
pubmed: 19478688
J Infect Dis. 2014 Nov 1;210(9):1415-8
pubmed: 24799600
J Pediatr. 2014 Apr;164(4):855-9
pubmed: 24433826
J Infect Dis. 2011 Oct 1;204(7):1003-7
pubmed: 21881114
Pediatrics. 2017 Feb;139(2):
pubmed: 28119425
Rev Med Virol. 2007 Sep-Oct;17(5):355-63
pubmed: 17542052
Rev Med Virol. 2017 Sep 6;:
pubmed: 28876493
N Engl J Med. 2015 Mar 5;372(10):933-43
pubmed: 25738669
Lancet Infect Dis. 2017 Jun;17(6):e177-e188
pubmed: 28291720
Pediatrics. 2014 Nov;134(5):972-82
pubmed: 25349318
Int J Infect Dis. 2014 May;22:44-8
pubmed: 24631522
Neonatology. 2016;110(4):277-285
pubmed: 27344149
Pediatrics. 2006 Jan;117(1):e76-83
pubmed: 16326692
Pediatr Infect Dis J. 2008 Sep;27(9):841-3
pubmed: 18645544
J Infect Dis. 2018 Apr 23;217(10):1612-1615
pubmed: 29401303
Clin Infect Dis. 2019 Oct 15;69(9):1526-1532
pubmed: 30596974
Pediatr Infect Dis J. 2016 Aug;35(8):924-6
pubmed: 27195603
PLoS Pathog. 2011 May;7(5):e1001344
pubmed: 21625576
Clin Infect Dis. 2019 Oct 30;69(10):1789-1796
pubmed: 30615106
Neuropediatrics. 2004 Apr;35(2):113-9
pubmed: 15127310
BJOG. 2008 Jun;115(7):830-5
pubmed: 18485160
Clin Infect Dis. 2010 Jul 1;51(1):33-41
pubmed: 20504230
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4120-8
pubmed: 26150505
Pediatrics. 2017 Nov;140(5):
pubmed: 29066580
J Pediatr. 2005 Jun;146(6):817-23
pubmed: 15973325
J Pediatr. 2018 Sep;200:196-201.e1
pubmed: 29784513
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5693-5698
pubmed: 30819890
Pediatrics. 2017 Feb;139(2):
pubmed: 28049114
Clin Infect Dis. 2009 Aug 15;49(4):522-8
pubmed: 19583520
N Engl J Med. 2006 May 18;354(20):2151-64
pubmed: 16707752
J Clin Virol. 2006 Feb;35(2):216-20
pubmed: 16368262
J Pediatr. 2013 Sep;163(3):828-34.e1
pubmed: 23587436
J Am Acad Audiol. 2000 May;11(5):283-90
pubmed: 10821506
Pediatr Infect Dis J. 1992 Feb;11(2):93-9
pubmed: 1311066
J Pediatr. 1999 Jul;135(1):60-4
pubmed: 10393605
J Pediatric Infect Dis Soc. 2019 Jul 1;8(3):205-212
pubmed: 29554325
Rev Med Virol. 2013 Jul;23(4):241-9
pubmed: 23559569
J Pediatr. 2010 Aug;157(2):191-7
pubmed: 20400091
Ultrasound Obstet Gynecol. 2013 May;41(5):508-14
pubmed: 23288698
Pediatr Infect Dis J. 2013 Oct;32(10):1050-4
pubmed: 23694837
Clin Infect Dis. 2011 Mar 1;52(5):575-81
pubmed: 21292661
Arch Dis Child Fetal Neonatal Ed. 2008 Jul;93(4):F280-5
pubmed: 18039747
Brain Dev. 2014 Mar;36(3):203-11
pubmed: 23647916
J Pediatr. 2016 May;172:110-115.e2
pubmed: 26858192
J Clin Virol. 2017 Jun;91:31-35
pubmed: 28412596
J Clin Virol. 2009 Dec;46 Suppl 4:S37-42
pubmed: 19781984
J Clin Virol. 2006 Jul;36(3):228-30
pubmed: 16750653
J Clin Virol. 2017 Dec;97:59-63
pubmed: 29149633
J Pediatr. 2001 Mar;138(3):325-31
pubmed: 11241037
J Pediatr. 2006 Mar;148(3):332-6
pubmed: 16615962
Rev Med Virol. 2007 Jul-Aug;17(4):253-76
pubmed: 17579921
J Clin Virol. 2000 Sep 1;17(3):159-65
pubmed: 10996112
Medicine (Baltimore). 2017 Feb;96(5):e6007
pubmed: 28151899
J Clin Microbiol. 2010 Nov;48(11):3956-62
pubmed: 20810771

Auteurs

Nazia Kabani (N)

Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Shannon A Ross (SA)

Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH